ACRS
Aclaris Therapeutics, Inc. · Healthcare · Market cap $819.9M
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Aug 4, 2026
Leonard Braden Michael
Aclaris Therapeutics, Inc. (ACRS) has 22 SEC Form 4 filings (41 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 4, 2026.
Inside the rolling window, 1 insider at Aclaris Therapeutics, Inc. reported no open-market purchases and 1 open-market sale totaling $1.4M. Insiders have net sold $1.4M over the trailing 6 months. The most recent open-market filing is a sale of 300,000 shares by Insider Leonard Braden Michael, dated Apr 23, 2026, worth $1.4M.
- Industry:Biotechnology
- CEO:Neal S. Walker
- Employees:71
- HQ:Wayne, PA, US
- IPO:2015-10-06
| Source | |||||||
|---|---|---|---|---|---|---|---|
Leonard Braden MichaelFirst in 5 months | Insider | Sale | 300,000 | $1.4M | Apr 27 | +26.3% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ACRS have?
Aclaris Therapeutics, Inc. (ACRS) has 22 SEC Form 4 filings (41 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Aug 4, 2026.
When was the most recent SEC Form 4 filing for ACRS?
The most recent Form 4 filing for ACRS on Tracefour is dated Aug 4, 2026.
What is the net insider flow at ACRS over the last 6 months?
Over the trailing 180 days, insiders at ACRS have net sold $1.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ACRS in the current window?
Inside the rolling window, insiders at ACRS bought $0 and sold $1.4M based on SEC Form 4 filings.
Can I get alerts for ACRS insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Aclaris Therapeutics, Inc. (ACRS). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Aclaris Therapeutics, Inc. is in the Healthcare sector.